Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer Bettina MeiserPhyllis ButowKatherine Tucker OriginalPaper Pages: 101 - 111
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67 William H. Goodson IIIDan H. Moore IIFrederic M. Waldman OriginalPaper Pages: 113 - 123
Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable? Ernest E. SternsBenny Zee OriginalPaper Pages: 125 - 132
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients Andrea MichelottiMarco VenturiniPierfranco Conte OriginalPaper Pages: 133 - 139
Infiltrating dendritic/Langerhans cells in primary breast cancer Tohru TsugeMitsunori YamakawaMasaru Tsukamoto OriginalPaper Pages: 141 - 152
Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer He YuBhupinder BharajEleftherios P. Diamandis OriginalPaper Pages: 153 - 161
Lipid peroxidation, free radical production and antioxidant status in breast cancer Gibanananda RaySanjay BatraSyed Akhtar Husain OriginalPaper Pages: 163 - 170
Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy R.K. GregoryT.J. PowlesM. Dowsett OriginalPaper Pages: 171 - 175
Surgical treatment of hepatic metastases from breast cancer Masataka YoshimotoTakashi TadaFujio Kasumi OriginalPaper Pages: 177 - 184
Survival and tumor characteristics of German hereditary breast cancer patients Ute HamannHans-Peter Sinn OriginalPaper Pages: 185 - 192
